Navigation Links
Kessler Foundation scientists awarded New Jersey grants for brain injury research

WEST ORANGE, N.J.Two neuroscientists at Kessler Foundation received grants from the New Jersey Commission on Brain Injury Research. Helen Genova, Ph.D., research scientist in Neuropsychology & Neuroscience Research was awarded a three-year Individual Research Grant totaling $462,103. Starla Weaver, Ph.D., a postdoctoral fellow in Traumatic Brain Injury (TBI) Research, received a three-year Fellowship Research Grant for $199,764. Kessler Foundation conducts cognitive and mobility rehabilitation research in brain injury, spinal cord injury, stroke and multiple sclerosis.

Nancy Chiaravalloti, Ph.D., director of Traumatic Brain Injury and Neuropsychology & Neuroscience Research, commented, "We are pleased to have the support of the Commission for these important studies. Expanding our knowledge of how TBI affects brain function will help us to devise more effective strategies for cognitive rehabilitation."

Dr. Genova is interested in the long-term cognitive dysfunction that can cause disability after brain injury. While some recover over time, a significant number of individuals show continued impairment and even progressive cognitive decline. The identification of an accurate and reliable predictor of cognitive outcome would help to guide patients and families through the recovery process, but such a predictor has eluded investigators. Dr. Genova will apply a new neuroimaging technique, diffusion tensor imaging (DTI), to the study of the cognitive effects of TBI. DTI has proven to be a highly sensitive measure of diffuse axonal injury and white matter integrity, but few studies have applied DTI to the study of cognitive deficits in people more than two years post TBI. Delineating the relationship between diffuse axonal injury and cognitive impairment could transform the initial approach to rehabilitation and enable clinicians to provide patients and families with prognostic information regarding cognitive recovery. Dr. Genova's project is "The longitudinal examination of the relationship between white matter pathology & cognitive impairment in traumatic brain injury using diffusion tensor imaging."

Dr. Weaver's interest is in chronic cognitive deficits that are a major cause of disability after TBI. Her research focuses on executive function, which is the ability to organize thoughts and activities, prioritize tasks, manage time efficiently, and make decisions. Developing rehabilitation interventions that improve executive function will minimize disability and aid performance of daily activities necessary for independent living. Task switching, i.e., the ability to switch between two simple tasks, has been found to be the best predictor of performance of tasks related to executive function. Dr. Weaver will compare the effects of task-switching in individuals with TBI and controls to determine whether this type of intervention can provide lasting benefits. She will use functional MRI to compare patterns of cerebral activation with task switching in both groups. Dr. Weaver's project is "The effects of task switching training on traumatic brain injury."

Drs. Genova, Weaver and Chiaravalloti have faculty appointments in the department of physical medicine & rehabilitation at UMDNJ-New Jersey Medical School.


Contact: Lauren Scrivo
Kessler Foundation

Related medicine news :

1. Kessler Foundation scientist garners best poster award for MS research
2. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
3. Kessler Foundation presents Brain Injury: From Research to Rebuilding Lives on Sept. 27-28
4. DeLuca of Kessler Foundation receives research award from American Psychological Association
5. Kessler Foundation and Heldrich Center issue brief on hiring workers with disabilities
6. Kessler Foundations A.M. Barrett appointed to National Quality Forum Steering Committee
7. Kessler Foundation scientists present cognitive research findings at MS dual symposium
8. Kessler Foundation researchers present at first International Congress on Cognition in MS
9. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
10. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
11. Research prizes from the Carlsberg Foundation to researchers from University of Copenhagen
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: